Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gynecological Malignancy”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Early research (Phase 1)Not Yet RecruitingNCT07778862
What this trial is testing

SI-B036 in Patients With Locally Advanced or Metastatic Gynecological Tumors and Other Solid Tumors

Who this might be right for
Gynecological TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 30
Large-scale testing (Phase 3)Ended earlyNCT00332280
What this trial is testing

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Who this might be right for
Gastrointestinal CancerProstate CancerGenital Neoplasms, Female
Auron Healthcare GmbH 67
Testing effectiveness (Phase 2)Looking for participantsNCT06798207
What this trial is testing

A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced

Who this might be right for
Gynecological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 170
Not applicableEnded earlyNCT03993210
What this trial is testing

The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Who this might be right for
Gynecologic Tumor
Dana-Farber Cancer Institute 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738757
What this trial is testing

SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies

Who this might be right for
Recurrent or Metastatic MSI-H/dMMR Gynecological Malignancies
Peking Union Medical College Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT06906341
What this trial is testing

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms+1 more
Corcept Therapeutics 270
Not applicableStudy completedNCT02172638
What this trial is testing

Postoperatory Recovery in Advanced Ovarian Cancer, Fast-Track Protocol vs. Classical Management

Who this might be right for
Median Length of StayReadmission RateSurgery Related Complications Rate+1 more
Hospital Universitari Vall d'Hebron Research Institute 110
Not applicableEnded earlyNCT06191900
What this trial is testing

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)

Who this might be right for
AdultGynecological Tumors
Grit Biotechnology 4
Testing effectiveness (Phase 2)Looking for participantsNCT06796907
What this trial is testing

Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

Who this might be right for
Tumours, Gynecological
GlaxoSmithKline 305
Testing effectiveness (Phase 2)Study completedNCT01399658
What this trial is testing

Image-Guided Gynecologic Brachytherapy

Who this might be right for
Cervical CancerUterine CancerVaginal Cancer+1 more
Dana-Farber Cancer Institute 93
Early research (Phase 1)Ended earlyNCT06130254
What this trial is testing

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Who this might be right for
Advanced Solid TumorNon-small Cell Lung Cancers
M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)Study completedNCT00850772
What this trial is testing

Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Queensland Centre for Gynaecological Cancer 109
Not applicableStudy completedNCT02340715
What this trial is testing

Advanced MRI Sequences for Radiation Therapy Treatment Planning

Who this might be right for
Cancer
Medical College of Wisconsin 158
Early research (Phase 1)Active Not RecruitingNCT05462717
What this trial is testing

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more
Revolution Medicines, Inc. 222
Large-scale testing (Phase 3)Study completedNCT02855944
What this trial is testing

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 349
Early research (Phase 1)Study completedNCT01065662
What this trial is testing

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

Who this might be right for
Endometrial CancerOvarian CancerCervical Cancer+2 more
Susana M. Campos, MD 11
Not applicableLooking for participantsNCT06232213
What this trial is testing

Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model

Who this might be right for
Personalized Cancer Treatment
Hua Li 40
Early research (Phase 1)Study completedNCT02978755
What this trial is testing

First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers

Who this might be right for
Neoplasm, Gynecologic
GamaMabs Pharma 78
Next Page